{"entity":{"type":"insider","cik":"0001495904","url":"/insider/0001495904","json_url":"/insider/0001495904.json","name":"Lemkey John G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":108,"n_filings":28,"first":"2017-12-08","last":"2020-09-30","span_basis":"filed_date"},"name_variants":[{"name":"Lemkey John G","source":"filing","n_filings":28,"first_seen":"2017-12-08","last_seen":"2020-09-30"}],"transactions":[{"id":2192084,"accession":"0001209191-20-052437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-052437","line_url":"/filing/0001209191-20-052437#line-2","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10882.0,"shares_display":"10,882","price_per_share":13.8484,"price_display":"13.85","price_state":"stated","total_value":150698.2888,"total_display":"150,698.29","total_whole":"150,698","shares_owned_after":15238782.0,"shares_owned_after_display":"15,238,782","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-29","filed_date":"2020-09-30","scope":"insider"},{"id":2192081,"accession":"0001209191-20-052437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-052437","line_url":"/filing/0001209191-20-052437#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":13.0571,"price_display":"13.06","price_state":"stated","total_value":1305710.0,"total_display":"1,305,710.00","total_whole":"1,305,710","shares_owned_after":15227900.0,"shares_owned_after_display":"15,227,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-28","filed_date":"2020-09-30","scope":"insider"},{"id":3323559,"accession":"0001209191-20-048868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-048868","line_url":"/filing/0001209191-20-048868#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Lemkey John G","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1052631.0,"shares_display":"1,052,631","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":14999991.75,"total_display":"14,999,991.75","total_whole":"14,999,992","shares_owned_after":15127900.0,"shares_owned_after_display":"15,127,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-28","filed_date":"2020-09-01","scope":"insider"},{"id":7927390,"accession":"0001209191-19-039458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-039458","line_url":"/filing/0001209191-19-039458#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; Hearne Michael S; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":769231.0,"shares_display":"769,231","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":20000006.0,"total_display":"20,000,006.00","total_whole":"20,000,006","shares_owned_after":14075269.0,"shares_owned_after_display":"14,075,269","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-26","filed_date":"2019-06-28","scope":"insider"},{"id":8701976,"accession":"0001209191-19-037895","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-037895","line_url":"/filing/0001209191-19-037895#line-4","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Lemkey John G; Hearne Michael S; TANG CAPITAL PARTNERS LP","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21350.0,"shares_display":"21,350","price_per_share":26.8862,"price_display":"26.89","price_state":"stated","total_value":574020.37,"total_display":"574,020.37","total_whole":"574,020","shares_owned_after":13306038.0,"shares_owned_after_display":"13,306,038","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-18","scope":"insider"},{"id":8701973,"accession":"0001209191-19-037895","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-037895","line_url":"/filing/0001209191-19-037895","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Lemkey John G; Hearne Michael S; TANG CAPITAL PARTNERS LP","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10042.0,"shares_display":"10,042","price_per_share":26.810539633539136,"price_display":"26.81","price_state":"stated","total_value":269231.439,"total_display":"269,231.44","total_whole":"269,231","shares_owned_after":13284688.0,"shares_owned_after_display":"13,284,688","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-18","scope":"insider","n_lines":2},{"id":8701968,"accession":"0001209191-19-037895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-037895","line_url":"/filing/0001209191-19-037895#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Lemkey John G; Hearne Michael S; TANG CAPITAL PARTNERS LP","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18608.0,"shares_display":"18,608","price_per_share":24.9513,"price_display":"24.95","price_state":"stated","total_value":464293.7904,"total_display":"464,293.79","total_whole":"464,294","shares_owned_after":13274646.0,"shares_owned_after_display":"13,274,646","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-14","filed_date":"2019-06-18","scope":"insider"},{"id":8391884,"accession":"0001209191-19-035995","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-035995","line_url":"/filing/0001209191-19-035995#line-4","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Hearne Michael S","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":26.311,"price_display":"26.31","price_state":"stated","total_value":526220.0,"total_display":"526,220.00","total_whole":"526,220","shares_owned_after":13256038.0,"shares_owned_after_display":"13,256,038","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-07","filed_date":"2019-06-10","scope":"insider"},{"id":8391880,"accession":"0001209191-19-035995","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-035995","line_url":"/filing/0001209191-19-035995","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Hearne Michael S","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56308.0,"shares_display":"56,308","price_per_share":27.726731995453576,"price_display":"27.73","price_state":"stated","total_value":1561236.8252,"total_display":"1,561,236.83","total_whole":"1,561,237","shares_owned_after":13227350.0,"shares_owned_after_display":"13,227,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-06","filed_date":"2019-06-10","scope":"insider","n_lines":3},{"id":8158690,"accession":"0001209191-19-034851","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-034851","line_url":"/filing/0001209191-19-034851","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S; TANG CAPITAL PARTNERS LP","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39456.0,"shares_display":"39,456","price_per_share":25.865286678832117,"price_display":"25.87","price_state":"stated","total_value":1020540.7512,"total_display":"1,020,540.75","total_whole":"1,020,541","shares_owned_after":13179730.0,"shares_owned_after_display":"13,179,730","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-05","scope":"insider","n_lines":2},{"id":8158678,"accession":"0001209191-19-034851","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-034851","line_url":"/filing/0001209191-19-034851","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S; TANG CAPITAL PARTNERS LP","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38950.0,"shares_display":"38,950","price_per_share":24.923539101412068,"price_display":"24.92","price_state":"stated","total_value":970771.848,"total_display":"970,771.85","total_whole":"970,772","shares_owned_after":13136038.0,"shares_owned_after_display":"13,136,038","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-05","scope":"insider","n_lines":2},{"id":8158665,"accession":"0001209191-19-034851","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-034851","line_url":"/filing/0001209191-19-034851","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S; TANG CAPITAL PARTNERS LP","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15286.0,"shares_display":"15,286","price_per_share":22.4979849012168,"price_display":"22.50","price_state":"stated","total_value":343904.1972,"total_display":"343,904.20","total_whole":"343,904","shares_owned_after":13093897.0,"shares_owned_after_display":"13,093,897","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-05","scope":"insider","n_lines":2},{"id":8724716,"accession":"0001209191-19-018545","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-018545","line_url":"/filing/0001209191-19-018545","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":18.745834114,"price_display":"18.75","price_state":"stated","total_value":1874583.4114,"total_display":"1,874,583.41","total_whole":"1,874,583","shares_owned_after":13086038.0,"shares_owned_after_display":"13,086,038","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-11","scope":"insider","n_lines":2},{"id":8724711,"accession":"0001209191-19-018545","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-018545","line_url":"/filing/0001209191-19-018545","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":17.04331659,"price_display":"17.04","price_state":"stated","total_value":681732.6636,"total_display":"681,732.66","total_whole":"681,733","shares_owned_after":12986038.0,"shares_owned_after_display":"12,986,038","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-07","filed_date":"2019-03-11","scope":"insider","n_lines":3},{"id":6267994,"accession":"0001209191-18-064413","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-064413","line_url":"/filing/0001209191-18-064413","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Lemkey John G; Hearne Michael S","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33700.0,"shares_display":"33,700","price_per_share":13.677414243323442,"price_display":"13.68","price_state":"stated","total_value":460928.86,"total_display":"460,928.86","total_whole":"460,929","shares_owned_after":12942338.0,"shares_owned_after_display":"12,942,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-31","filed_date":"2018-12-31","scope":"insider","n_lines":4},{"id":6267990,"accession":"0001209191-18-064413","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-064413","line_url":"/filing/0001209191-18-064413","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Lemkey John G; Hearne Michael S","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":12.69315,"price_display":"12.69","price_state":"stated","total_value":253863.0,"total_display":"253,863.00","total_whole":"253,863","shares_owned_after":12912338.0,"shares_owned_after_display":"12,912,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-28","filed_date":"2018-12-31","scope":"insider","n_lines":2},{"id":6267988,"accession":"0001209191-18-064413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-064413","line_url":"/filing/0001209191-18-064413#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Lemkey John G; Hearne Michael S","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":12.0315,"price_display":"12.03","price_state":"stated","total_value":120315.0,"total_display":"120,315.00","total_whole":"120,315","shares_owned_after":12892338.0,"shares_owned_after_display":"12,892,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-27","filed_date":"2018-12-31","scope":"insider"},{"id":6106267,"accession":"0001209191-18-064127","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-064127","line_url":"/filing/0001209191-18-064127","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Lemkey John G; TANG CAPITAL PARTNERS LP; Hearne Michael S","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":12.276233333333334,"price_display":"12.28","price_state":"stated","total_value":368287.0,"total_display":"368,287.00","total_whole":"368,287","shares_owned_after":12862338.0,"shares_owned_after_display":"12,862,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-26","scope":"insider","n_lines":3},{"id":6106257,"accession":"0001209191-18-064127","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-064127","line_url":"/filing/0001209191-18-064127","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Lemkey John G; TANG CAPITAL PARTNERS LP; Hearne Michael S","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":12.7913875,"price_display":"12.79","price_state":"stated","total_value":255827.75,"total_display":"255,827.75","total_whole":"255,828","shares_owned_after":12842338.0,"shares_owned_after_display":"12,842,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-21","filed_date":"2018-12-26","scope":"insider","n_lines":3},{"id":6106250,"accession":"0001209191-18-064127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-064127","line_url":"/filing/0001209191-18-064127#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Lemkey John G; TANG CAPITAL PARTNERS LP; Hearne Michael S","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":13.1742,"price_display":"13.17","price_state":"stated","total_value":131742.0,"total_display":"131,742.00","total_whole":"131,742","shares_owned_after":12832338.0,"shares_owned_after_display":"12,832,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-20","filed_date":"2018-12-26","scope":"insider"},{"id":6398021,"accession":"0001209191-18-063288","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-063288","line_url":"/filing/0001209191-18-063288","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11704.0,"shares_display":"11,704","price_per_share":14.28474094326726,"price_display":"14.28","price_state":"stated","total_value":167188.608,"total_display":"167,188.61","total_whole":"167,189","shares_owned_after":12822338.0,"shares_owned_after_display":"12,822,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-18","filed_date":"2018-12-18","scope":"insider","n_lines":2},{"id":6398016,"accession":"0001209191-18-063288","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-063288","line_url":"/filing/0001209191-18-063288","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18296.0,"shares_display":"18,296","price_per_share":14.6814764538697,"price_display":"14.68","price_state":"stated","total_value":268612.2932,"total_display":"268,612.29","total_whole":"268,612","shares_owned_after":12801888.0,"shares_owned_after_display":"12,801,888","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-17","filed_date":"2018-12-18","scope":"insider","n_lines":3},{"id":6398002,"accession":"0001209191-18-063288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-063288","line_url":"/filing/0001209191-18-063288#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":15.0838,"price_display":"15.08","price_state":"stated","total_value":150838.0,"total_display":"150,838.00","total_whole":"150,838","shares_owned_after":12792338.0,"shares_owned_after_display":"12,792,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-14","filed_date":"2018-12-18","scope":"insider"},{"id":6267949,"accession":"0001209191-18-062539","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-062539","line_url":"/filing/0001209191-18-062539","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14550.0,"shares_display":"14,550","price_per_share":15.735086597938144,"price_display":"15.74","price_state":"stated","total_value":228945.51,"total_display":"228,945.51","total_whole":"228,946","shares_owned_after":12782338.0,"shares_owned_after_display":"12,782,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-13","scope":"insider","n_lines":2},{"id":6267947,"accession":"0001209191-18-062539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-062539","line_url":"/filing/0001209191-18-062539#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5450.0,"shares_display":"5,450","price_per_share":15.2528,"price_display":"15.25","price_state":"stated","total_value":83127.76,"total_display":"83,127.76","total_whole":"83,128","shares_owned_after":12767788.0,"shares_owned_after_display":"12,767,788","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-13","scope":"insider"},{"id":6805219,"accession":"0001209191-18-061861","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-061861","line_url":"/filing/0001209191-18-061861#line-3","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":14.978,"price_display":"14.98","price_state":"stated","total_value":142291.0,"total_display":"142,291.00","total_whole":"142,291","shares_owned_after":12762338.0,"shares_owned_after_display":"12,762,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2018-12-10","scope":"insider"},{"id":6805216,"accession":"0001209191-18-061861","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-061861","line_url":"/filing/0001209191-18-061861","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10500.0,"shares_display":"10,500","price_per_share":14.625990476190475,"price_display":"14.63","price_state":"stated","total_value":153572.9,"total_display":"153,572.90","total_whole":"153,573","shares_owned_after":12752338.0,"shares_owned_after_display":"12,752,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-10","scope":"insider","n_lines":2},{"id":6267887,"accession":"0001209191-18-060245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-060245","line_url":"/filing/0001209191-18-060245#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3063.0,"shares_display":"3,063","price_per_share":15.6423,"price_display":"15.64","price_state":"stated","total_value":47912.3649,"total_display":"47,912.36","total_whole":"47,912","shares_owned_after":12742338.0,"shares_owned_after_display":"12,742,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-27","filed_date":"2018-11-29","scope":"insider"}],"collapsed":true,"next_cursor":"2018-11-27|6267887","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001717452","name":"Odonate Therapeutics, Inc.","url":"/issuer/0001717452","role":"Officer (Chief Operating Officer)","n_filings":28,"first_seen":"2017-12-08","last_seen":"2020-09-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001495904","retrieved_at":"2026-08-23T04:39:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}